Tilray Brands (TLRY) Amortization - Intangibles (2021 - 2026)
Tilray Brands' (TLRY) quarterly Amortization - Intangibles came in at $6.2 million in Q2 2026, down 70.09% YoY from $20.7 million in Q2 2025, and up 21.27% on a QoQ basis from $5.1 million in Q1 2026.
Tilray Brands (TLRY) Amortization - Intangibles (2021 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 6 years of Amortization - Intangibles data on file, last reported at $6.2 million in Q2 2026.
- Quarterly Amortization - Intangibles fell 70.09% year-over-year to $6.2 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $19.6 million (down 77.9% YoY) and the FY2026 annual result came in at $19.6 million, down 77.9% from the prior year.
- Amortization - Intangibles climbed to $6.2 million in Q2 2026, from $5.1 million in the prior quarter.
- In the past five years, Amortization - Intangibles ranged from a high of $30.8 million in Q2 2022 to a low of $3.9 million in Q3 2025.
- A 5-year average of $19.0 million and a median of $21.9 million in 2023 frame the typical range for Amortization - Intangibles.
- The widest YoY moves for Amortization - Intangibles: up 8.67% in 2025, down 81.98% in 2025.
- Tracing TLRY's Amortization - Intangibles over 5 years: stood at $24.0 million in 2022, then declined by 8.66% to $21.9 million in 2023, then grew by 4.61% to $22.9 million in 2024, then tumbled by 80.99% to $4.4 million in 2025, then surged by 42.08% to $6.2 million in 2026.
- The last three Amortization - Intangibles figures came in at $6.2 million (Q2 2026), $5.1 million (Q1 2026), and $4.4 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Tilray Brands | 514.99 Mn | 280.36 Mn | 90.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 6.19 Mn |
| Feb 28, 2026 | 5.11 Mn |
| Nov 30, 2025 | 4.36 Mn |
| Aug 31, 2025 | 3.93 Mn |
| May 31, 2025 | 20.70 Mn |
| Feb 28, 2025 | 23.18 Mn |
| Nov 30, 2024 | 22.93 Mn |
| Aug 31, 2024 | 21.80 Mn |
| May 31, 2024 | 19.05 Mn |
| Feb 29, 2024 | 21.56 Mn |
| Nov 30, 2023 | 21.92 Mn |
| Aug 31, 2023 | 22.23 Mn |
| May 31, 2023 | 21.62 Mn |
| Feb 28, 2023 | 23.52 Mn |
| Nov 30, 2022 | 24.00 Mn |
| Aug 31, 2022 | 24.36 Mn |
| May 31, 2022 | 30.85 Mn |
| Feb 28, 2022 | 24.59 Mn |
| Nov 30, 2021 | 29.02 Mn |